Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Back%2C+David+J%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Back%2C+David+J%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Back%2C+David+J%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (10)
1
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
enthalten in:
Clinical pharmacology and therapeutics
| 2022
von
Marzolini, C.
|
Kuritzkes, D.
|
Marra, F.
| +9
CommentIn: Clin Pharmacol Ther. 2023 Apr;113(4):768-769. - PMID 36544259
Wird geladen...
2
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics
enthalten in:
bioRxiv.org
| 2022
von
Arshad, U.
|
Pertinez, H.
|
Box, H.
| +18
Wird geladen...
3
Fluvoxamine for the treatment of COVID-19
enthalten in:
The Lancet. Global health
| 2022
von
Marzolini, C.
|
Marra, F.
|
Boyle, A.
| +2
CommentOn: Lancet Glob Health. 2022 Jan;10(1):e42-e51. - PMID 34717820
Wird geladen...
4
Dexamethasone is a dose-dependent perpetrator of drug-drug interactions : implications for use in people living with HIV
enthalten in:
The Journal of antimicrobial chemotherapy
| 2022
von
Jacobs, T.
|
Marzolini, C.
|
Back, D.
| +1
Wird geladen...
5
Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
enthalten in:
Clinical Pharmacology & Therapeutics
| 2022
von
Marzolini, C.
|
Kuritzkes, D.
|
Marra, F.
| +9
Wird geladen...
6
Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID-19 Therapeutic Development
enthalten in:
Clinical pharmacology and therapeutics
| 2021
von
Boffito, M.
|
Back, D.
|
Flexner, C.
| +7
CommentIn: Clin Pharmacol Ther. 2021 Aug;110(2):294-296. - PMID 33410139
Wird geladen...
7
Prescribing in COVID-19 patients : Should we take into account inflammation?
enthalten in:
British journal of clinical pharmacology
| 2021
von
Marzolini, C.
|
Battegay, M.
|
Sendi, P.
| +1
Wird geladen...
8
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
enthalten in:
Clinical pharmacology and therapeutics
| 2020
von
Arshad, U.
|
Pertinez, H.
|
Box, H.
| +19
ErratumIn: Clin Pharmacol Ther. 2021 May;109(5):1362. - PMID 33870492
Wird geladen...
9
The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics
enthalten in:
The Journal of antimicrobial chemotherapy
| 2020
von
Siccardi, M.
|
Schapiro, J.
|
Di Perri, G.
| +1
Wird geladen...
10
Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
enthalten in:
Clinical Pharmacology & Therapeutics
| 2020
von
Arshad, U.
|
Pertinez, H.
|
Box, H.
| +19
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
3
Clinical pharmacology and therapeutics
2
Clinical Pharmacology & Therapeutics
2
The Journal of antimicrobial chemotherapy
1
British journal of clinical pharmacology
1
The Lancet. Global health
1
bioRxiv.org
Alle anzeigen ...
weniger ...
Thema
6
Journal Article
5
Antiviral Agents
5
Review
3
Research Support, Non-U.S. Gov't
1
570
1
7S5I7G3JQL
1
Anti-Inflammatory Agents
1
Antibodies, Viral
1
Biology
1
COVID-19
1
Comment
1
Cytochrome P-450 CYP3A
1
Dexamethasone
1
EC 1.14.14.1
1
Fluvoxamine
1
Letter
1
O3J8G9O825
1
O4L1XPO44W
1
Pharmaceutical Preparations
1
Research Support, N.I.H., Extramural
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2022
2
2021
3
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...